– Seasoned clinical development leader brings more than 25 years of deep expertise in clinical development and operations across biotech and healthcare industry – SAN DIEGO, Calif. – February 5, 2026 – ADARx Pharmaceuticals, Inc. (ADARx), a late-stage biotechnology company developing next-generation RNA therapeutics, today announced the appointment of Donald Fong, M.D., as Chief Medical Officer […] The post ADARx Pharmaceuticals Appoints Donald Fong, M.D., as Chief Medical Officer appeared first on ADARx Pharmaceuticals .
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules